Solr Search

a persistent yet addressable challenge., There are things we can and must collectively do as an industry to build a more inclusive future for clinical research. , It is not enough just to increase diversity.

h., Now is the time to encourage more funding for basic research to provide the best investments for future technology. , When the 118th Congress convenes in January, US lawmakers must seize on the momentum of the CHIPS and Science Act of 2022 and double down on science and innovation. Pennies pinched now could cost us trillions later.

making friends., If we want to solve the most difficult puzzles and break through barriers, we must construct a community of collaborators. , Creating Community The first and most critical step toward progress is an outstretched hand. If we don’t wish to be wandering the forest alone, we must be willing to invite others on our journey.

g, renowned molecular biologist and Nobel Laureate, Innovation will continue to provide new and more effective ways to fight our evolving enemy. , One example is Orna Therapeutics, a company developing the next generation of RNA technology: circular RNA. Circular RNA technology was originally invented at MIT and has immense potential to address key limitations of mRNA.

the modification or manipulation of gene expression, are becoming a clinical reality, holding incredible promise for millions of patients., Stakeholders must be proactive to effectively incorporate patient goals and perspectives throughout the gene therapy development process. , The Cystic Fibrosis Foundation is dedicated to ensuring that people with cystic fibrosis (CF) have the opportunity to lead long, fulfilling lives, with the ultimate goal of curing CF.